After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists?
Author:
Publisher
Elsevier BV
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference101 articles.
1. GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond;Ryan;Obes Silver Spring Md,2015
2. Pleiotropic effects of glucagon-like peptide-1 (GLP-1)-based therapies on vascular complications in diabetes;Yamagishi;Curr Pharm Des,2011
3. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury;Timmers;J Am Coll Cardiol,2009
4. GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice;Noyan-Ashraf;Diabetes,2009
5. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study;Woo;Arterioscler Thromb Vasc Biol,2013
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HIV-associated kidney disease: the changing spectrum and treatment priorities;Current Opinion in Nephrology & Hypertension;2024-08-20
2. Evolution of myocardial steatosis in patients with type 2 diabetes treated by GLP1 receptor agonists: LICAS study;2024-08-10
3. No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes;Diabetes & Metabolism;2024-05
4. Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trial;European Heart Journal - Cardiovascular Pharmacotherapy;2024-01-25
5. Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes;Biomedicines;2023-05-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3